Invention Grant
- Patent Title: Compositions and methods for achieving sustained therapeutic drug concentrations in a subject
-
Application No.: US15723981Application Date: 2017-10-03
-
Publication No.: US10525051B2Publication Date: 2020-01-07
- Inventor: Michael A. Eldon , Shibani S. Harite , Tamra L. Barker
- Applicant: Nektar Therapeutics
- Applicant Address: US CA San Francisco
- Assignee: Nektar Therapeutics
- Current Assignee: Nektar Therapeutics
- Current Assignee Address: US CA San Francisco
- Agent Susan T. Evans
- Main IPC: A61K31/4745
- IPC: A61K31/4745 ; A61K47/60
Abstract:
Provided herein are compounds and methods for achieving a sustained therapeutic effect of small molecule anti-cancer agents when administered in vivo.Sustained Exposure to Active Metabolite with PEG-Irinotecan
Public/Granted literature
- US20180028525A1 COMPOSITIONS AND METHODS FOR ACHIEVING SUSTAINED THERAPEUTIC DRUG CONCENTRATIONS IN A SUBJECT Public/Granted day:2018-02-01
Information query
IPC分类:
